Medical/Pharmaceuticals

COVID-19 Antibody Test Released by Ortho Clinical Diagnostics

RARITAN, New Jersey, April 4, 2020 /PRNewswire/ -- Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 To...

2020-04-04 07:06 2761

Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

SHANGHAI and SUZHOU, China, April 3, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell & gene therapy company, is pleased to announce that China National Medical Products Administration (NMPA) has accepted Gracell's Investigational New Drug (IND) ...

2020-04-03 22:00 1885

VUNO offers a suite of AI solutions in response to the COVID-19 outbreak: VUNO Med(R)- LungQuant(TM) and VUNO Med(R)-Chest X-ray(TM): COVID-19

SEOUL, South Korea, April 3, 2020 /PRNewswire/ -- In the face of the COVID-19 pandemic raging around the globe,VUNO, a member company of the Born2Global Centre, has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare com...

2020-04-03 20:30 1424

Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China

GERMANTOWN, Maryland, April 3, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced the completion of its new cell manufacturing facility in Suzhou,China. The facilit...

2020-04-03 20:00 2367

Ping An Donates £1.1m of COVID-19 Medical Supplies to the United Kingdom

HONG KONG and SHANGHAI, April 3, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced thatPing An and its Chairman Ma Mingzhe are now responding to the urgent needs of the British government by donating medical ...

2020-04-03 17:04 13103

CPhI & P-MEC China 2020 will join hands with P-Logi China 2020 and be held at Shanghai New International Expo Center in June

SHANGHAI, April 3, 2020 /PRNewswire/ -- To provide global vision and opportunities for the intelligent coordination between pharmaceutical enterprises and logistics service and equipment suppliers, P-Logi China 2020, organized by Informa Markets and CCCMHPIE and co-organized by Sinoexpo Informa ...

2020-04-03 17:02 2769

SonoScape supports frontline battle against COVID-19 in Spain

MADRID, April 3, 2020 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, has donated and delivered portable ultrasound systems to health care facilities where needed in Spain, pulling together to fight against COVID-19. COVID-19 has a foothol...

2020-04-03 16:50 5809

Automobili Lamborghini starts production of surgical masks and medical shields for use in Coronavirus pandemic

SANT'AGATA BOLOGNESE, Itlay, April 3, 2020 /PRNewswire/ -- Automobili Lamborghini is converting departments of its super sports car production plant in Sant'Agata Bolognese in order to produce surgical masks and protective plexiglass shields. The masks will be donated to the Sant'Orsola-Malpighi...

2020-04-03 15:33 1887

CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality

SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...

2020-04-03 09:12 4799

DERMALOG: Increasing Safety With Biometric Fever Screening

HAMBURG, Germany, April 2, 2020 /PRNewswire/ -- When it comes to a viral infection, fever is one of the most frequent symptoms. The German company DERMALOG has developed a camera, which measures body temperature with outstanding accuracy and speed to make a significant contribution to the contai...

2020-04-02 23:04 1888

Bracing for a long battle against COVID-19: General Use Face Shields designed by PolyU ready for mass production

HONG KONG, April 2, 2020 /PRNewswire/ -- The situation in Hong Kong has become more critical amid the rise of confirmed cases of COVID-19 infections. Experts have warned that members of the public should prepare for a long fight against the COVID-19 pandemic. Over the past few months, The Hong Ko...

2020-04-02 21:02 2872

Atomo secures significant European sales agreement for rapid COVID-19 tests as $30m Initial Public Offer closes oversubscribed

SYDNEY, April 3, 2020 /PRNewswire/ -- Australian rapid blood test company Atomo Diagnostics Limited today said it had entered into a binding supply agreement with French diagnostics company, NG Biotech, SAS (NG Biotech), for the supply of Atomo's integrated blood test devices to NG Biotech to use...

2020-04-02 21:01 2096

China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

-- XEN® Becomes the First Medical Product Approved by Using Real World Evidence inChina -- DUBLIN, April 2, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel Stent on March 26, 202...

2020-04-02 19:30 7545

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced preliminary data ...

2020-04-02 19:00 2228

Covid-19 Related Delays in the Ongoing Phase IIb-study are Expected to be Managed With Existing Funding

STOCKHOLM, April 2, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onApril 2 2020, that the company is now seeing signs of delays in the ongoing clinical phase IIb study with the drug candidate RV001 in prostate cancer, due to the Covid-19 pandemic. However, the company believes that ...

2020-04-02 17:17 1424

Jolly Good and National Center for Cognitive Behavior Therapy and Research Enter Clinical Trial Collaboration for VR Therapeutics

TOKYO, April 2, 2020 /PRNewswire/ -- Jolly Good Inc. (hereinafter "Jolly Good") and the National Center for Cognitive Behavior Therapy and Research (hereinafter "NCCBTR") announced that they have entered into a clinical trial collaboration agreement directed toward the development of digital heal...

2020-04-02 16:00 1286

Sai Life Sciences Becomes First India-headquartered Company to Join Pharmaceutical Supply Chain Initiative (PSCI)

HYDERABAD, India, April 2, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today announced its induction into the Pharmaceutical Suppl...

2020-04-02 14:47 3569

#StrengthsTogether - Cappfinity Offers Free Strengths Profiles to Help People Across the Globe Discover Their Strengths

NEW YORK, April 2, 2020 /PRNewswire/ -- During April, HR tech firm, Cappfinity, is giving away free Strengths Profiles to help people around the world use their strengths to build resilience, support others, and cope with the stresses created by the unfolding crisis. Based on two decades of posi...

2020-04-02 06:00 2059

MegaRing, Applied Towards Monitoring Pneumonia Patients in Wuhan, Wins Red Dot Award

HANGZHOU, China, April 2, 2020 /PRNewswire/ -- The 2020 Germany Red Dot Design Award revealed recently that the Hangzhou Megasens Technology Co., Ltd developed MegaRing - a finger wearable ring largely applied for help against COVID-19 by way of monitoring vital physiological parameters like b...

2020-04-02 05:10 2763

Icon Group Partners with Varian to Advance Cancer Care in the Southern Hemisphere

SYDNEY, April 2, 2020 /PRNewswire/ -- The Icon Cancer Centre Wahroonga in Australia has treated its first cancer patient with Varian Ethos™. This artificial intelligence (AI)-driven holistic adaptive therapy solution is designed to deliver an entire adapted treatment in a typical 15-minute timesl...

2020-04-02 05:00 9175
1 ... 582583584585586587588 ... 610

Week's Top Stories